Patent No. EP3488847 (titled "Semifluorinated Alkane Compositions") was filed by Novaliq on Sep 12, 2013. The application was issued on Nov 8, 2023.
A novel formulation for dry eye treatment that eliminates preservatives while maintaining therapeutic efficacy. The formulation comprises a semifluorinated alkane with a contact angle of 100-100°, which prevents microbial growth and irritation while maintaining tear film stability. The formulation can be used as a topical treatment for dry eye syndrome, including symptoms such as dryness, grittiness, and foreign body sensation.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description